Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 4:2019:2107821.
doi: 10.1155/2019/2107821. eCollection 2019.

Advance Directives of German People with Parkinson's Disease Are Unspecific in regard to Typical Complications

Affiliations

Advance Directives of German People with Parkinson's Disease Are Unspecific in regard to Typical Complications

Martin Klietz et al. Parkinsons Dis. .

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative movement disorder with an increased morbidity and mortality. People with PD (PwP) may suffer from decreased quality of life due to various motor and nonmotor symptoms. To a huge proportion, PwP have written an advance directive (AD); however, the content of these forms in regard to PD-specific complications is unclear. The aim of this study was to qualitatively and quantitatively analyze ADs of PwP in Germany. ADs of PwP were analyzed in a German sample of members of the German PD patient association. Participants completed a questionnaire about their AD and sent a copy of their AD to the study center for detailed analyses. ADs were qualitatively and quantitatively analyzed for general and PD-specific aspects and usefulness concerning treatment decisions. 82 PwP were included in the study, and in 76, an AD could be analyzed. Family members, notaries, lawyers, and general physicians mainly counseled writing of the ADs. 4 PwP consulted a neurologist to establish a specific AD for PD. In the analysis, ADs displayed a good specificity for general aspects, but they were unspecific to PD in the vast majority of cases. PwP should be encouraged to create an AD early in their disease and adapt it in the course of the disease. PD-specific aspects for an AD could be details in relation to dopaminergic therapies at the end of life, management of non-oral advanced therapies, neuropsychiatric symptoms, dementia, and swallowing disturbances.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to report.

Figures

Figure 1
Figure 1
Analysis of general and specific aspects of the advance directives (ADs) of 76 people with Parkinson's disease. Green color indicates the amount of clear and specific wishes of the patients concerning individual aspects of their AD. Yellow indicates the amount of mentioned but unspecific wishes of the patients in relation to individual aspects of the AD with no clear guideline for the clinical management. Red indicates the amount of neglected aspects. Abbreviations: PD, Parkinson's disease; LCIG, levodopa-carbidopa intestinal gel.

Similar articles

Cited by

References

    1. Nussbaum R. L., Ellis C. E. Alzheimer’s disease and Parkinson’s disease. New England Journal of Medicine. 2003;348(14):1356–1364. doi: 10.1056/NEJM2003ra020003. - DOI - PubMed
    1. Bach J.-P., Ziegler U., Deuschl G., Dodel R., Doblhammer-Reiter G. Projected numbers of people with movement disorders in the years 2030 and 2050. Movement Disorders. 2011;26(12):2286–2290. doi: 10.1002/mds.23878. - DOI - PubMed
    1. Macleod A. D., Taylor K. S. M., Counsell C. E. Mortality in Parkinson’s disease: a systematic review and meta-analysis. Movement Disorders. 2014;29(13):1615–1622. doi: 10.1002/mds.25898. - DOI - PubMed
    1. Tuck K. K., Zive D. M., Schmidt T. A., Carter J., Nutt J., Fromme E. K. Life-sustaining treatment orders, location of death and co-morbid conditions in decedents with Parkinson’s disease. Parkinsonism & Related Disorders. 2015;21(10):1205–1209. doi: 10.1016/j.parkreldis.2015.08.021. - DOI - PubMed
    1. Pennington S., Snell K., Lee M., Walker R. The cause of death in idiopathic Parkinson’s disease. Parkinsonism & Related Disorders. 2010;16(7):434–437. doi: 10.1016/j.parkreldis.2010.04.010. - DOI - PubMed

LinkOut - more resources